Biomedical Nanotechnology

Biomedical Nanotechnology.- Multiplexed Detection of Oligonucleotides with Biobarcoded Gold Nanoparticle Probes.- Molecular Detection of Biomarkers and Cells Using Magnetic Nanoparticles and Diagnostic Magnetic Resonance.- Real-Time Quantum Dot Tracking of Single Proteins.- Titanium Dioxide Nanoparticles in Advanced Imaging and Nanotherapeutics.- Surface Modification and Biomolecule Immobilization on Polymer Spheres for Biosensing Applications.- Multivalent Conjugation of Peptides, Proteins, and DNA to Semiconductor Quantum Dots.- A Single SnO2 Nanowire-Based Microelectrode.- Biosensing Using Nanoelectromechanical Systems (NEMS).- Nano “Fly Paper” Technology for the Capture of Circulating Tumor Cells.- Polymeric Nanoparticles for Photodynamic Therapy.- Hydrogel Templates for the Fabrication of Homogeneous Polymer Microparticles.- Antibacterial Application of Engineered Bacteriophage Nanomedicines: Antibody-Targeted, Chloramphenicol Prodrug Loaded Bacteriophages for Inhibiting the Growth of Staphylococcus aureus Bacteria.- Viruses as Nanomaterials for Drug Delivery.- Applications of Carbon Nanotubes in Biomedical Studies.- Electrospun Nanofibrous Scaffolds for Engineering Soft Connective Tissues.- Peptide Amphiphiles and Porous Biodegradable Scaffolds for Tissue Regeneration in the Brain and Spinal Cord.- Computational Simulations of the Interaction of Lipid Membranes with DNA-Functionalized Gold Nanoparticles.- Cytotoxic Assessment of Carbon Nanotube Interaction with Cell Cultures.- Nanoparticle Toxicology:  Measurements of Pulmonary Hazard Effects Following Exposures to Nanoparticles.- Nanoparticle Therapeutics: FDA Approval, Clinical Trials, Regulatory Pathways, and Case Study.- Legislating the Laboratory?: Promotion and Precaution in a Nanomaterials Company.- Navigating the Patent Landscapes for Nanotechnology: English Gardens or Tangled Grounds?.- Scientific Entrepreneurship in the Materials and Life Science Industries.- Applying the Marketing Mix (5 P’s) to Bionanotechnology.- Managing the “Known Unknowns”: Theranostic Cancer Nanomedicine and Informed Consent.